2014-24035. Manufacturer of Controlled Substances Registration: Siemens Healthcare Diagnostics, Inc.  

  • Start Preamble

    ACTION:

    Notice of registration.

    SUMMARY:

    Siemens Healthcare Diagnostics, Inc., applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Siemens Healthcare Diagnostics, Inc. registration as a manufacturer of those controlled substances.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    By notice dated May 2, 2014, and published in the Federal Register on May 15, 2014, 79 FR 27936, Siemens Healthcare Diagnostics, Inc., Attn: RA, 100 GBC Drive, Mailstop 514, Newark, Delaware 19702, applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice.

    The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Siemens Healthcare Diagnostics, Inc., to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed:

    Controlled substanceSchedule
    Tetrahydrocannabinols (7370)I
    Ecgonine (9180)II
    Morphine (9300)II

    The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator controls which are DEA exempt products.

    In reference to drug code 7370 the company plans to bulk manufacture a synthetic tetrahydrocannabinol. No other activity for this drug code is authorized for this registration.

    Start Signature

    Dated: October 1, 2014.

    Joseph T. Rannazzisi,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2014-24035 Filed 10-7-14; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
10/08/2014
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of registration.
Document Number:
2014-24035
Pages:
60865-60865 (1 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2014-24035.pdf